Selected Tag: Granules

Selected Tag: Granules

Most Indian Pharma Exports May Escape US Tariff, But Uncertainty Clouds Branded Generics

US 100% tariff plan sparks confusion: if branded generics are treated as patented drugs, India is safe; if as branded imports, then some pharma exports face trouble.

Ajay Srivastava

September 26, 2025 at 7:56 AM IST

Article related image

Istock.com/moussa81

Granules India's Joint MD & CEO Kandiraju Rao Resigns, Effective July 31

BasisPoint Insight

July 21, 2025 at 9:24 AM IST

Granules India Extends ₹2.7 Billion Guarantee For Swiss Unit’s MUFG Bank Loan

BasisPoint Insight

July 11, 2025 at 7:16 AM IST

Granules India's US Unit Gets One FDA Observation, Says Issue Resolved

BasisPoint Insight

June 30, 2025 at 9:56 AM IST

Granules India Gets One USFDA Observation For Hyderabad API Plant

BasisPoint Insight

June 23, 2025 at 10:26 AM IST

Granules India January-March Profit Up 17% On Year; 2024-25 Earnings Rise 24%

BasisPoint Insight

May 30, 2025 at 8:14 AM IST

Granules India Completes Acquisition Of Swiss Peptide Maker Senn Chemicals

BasisPoint Insight

April 11, 2025 at 3:53 PM IST

The Bureau

US Shutdown Uncertainty Fuels Safe-Haven Demand, Drive Dollar Weakness

Benign Inflation, External Risks Keep Rate-Cut Debate Open, But for December

Most Indian Pharma Exports May Escape US Tariff, But Uncertainty Clouds Branded Generics

Moody’s Affirms India at Baa3, Flags Fiscal Constraints and Tariff Uncertainty

India’s Second Half Borrowing Plan Balances Market Needs, But Yield Relief Hinges on RBI

Eight Years, Many Judgements Later Bhushan Power Stays with JSW

PM Modi Links Swadeshi Push to GST Reforms, Income Tax Relief; Calls for Atmanirbhar Bharat

$100K for H1B visas: Trump's Tirade Against India Continues

Jallikattu: Tamil Nadu’s Ancient Bull-Taming Tradition